Antonini M, Oliveira LL, Mattar A, Cavalcante FP, Millen EC, Zerwes F, et al. Updated meta-analysis of randomized trials: pathological complete response as a prognostic marker for survival in breast cancer treated with neoadjuvant chemotherapy. MAST [Internet]. 2026 Feb. 24 [cited 2026 May 1];35(suppl.1). Available from: https://mastology.org/journal/article/view/1168